Abstract
The whey acidic protein (WAP) domain is a conserved motif, containing eight cysteines found in a characteristic 4-disulphide core arrangement, that is present in a number of otherwise unrelated proteins. WAP motifs are present in SLPI and elafin, two antiproteinases located on chromosome 20q12-13, in a locus rich in poorly characterized WAP domain proteins. One of these proteins, which contains two WAP domains, is HE4 (also known as WFDC2), originally described as an epididymis specific protein but more recently suggested to be a putative serum tumour marker for ovarian cancer. We have shown that HE4 is expressed in a number of normal human tissues outside of the male reproductive system, including regions of the respiratory tract and nasopharynx, as well as in a subset of lung tumour cell lines. Comparison of multiple HE4 cDNAs and RT–PCR products with genomic sequence allowed the elucidation of the genomic organization. These studies revealed that HE4 can undergo a complex series of alternative splicing events that can potentially yield five distinct WAP domain containing protein isoforms. These results cast doubt on the potential role of HE4 as a serum tumour marker specific for ovarian cancer and open the door to understanding the function of multiple WAP domain containing protein isoforms arising from a single gene.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bingle CD, Bingle L . 2000 Biochim. Biophys. Acta 1493: 363–367
Bingle L, Tetley TD, Bingle CD . 2001 Am. J. Respir. Cell Mol. Biol. 25: 84–91
Ellerbrock K, Pera I, Hartung S, Ivell R . 1994 Int. J. Androl. 17: 314–323
Hough CD, Sherman-Baust CA, Pizer ES, Montz FJ, Im DD, Rosenshein NB, Cho KR, Riggins GJ, Morin PJ . 2000 Cancer Res. 60: 6281–6287
Imai FL, Uzawa K, Miyakawa A, Shiiba M, Tanzawa H . 2001 Int. J. Mol. Med. 7: 43–47
Jia HP, Schutte BC, Schudy A, Linzmeier R, Guthmiller JM, Johnson GK, Tack BF, Mitros JP, Rosenthal A, Ganz T, McCray Jr PB . 2001 Gene 263: 211–218
Kirchhoff C . 1998 Rev. Reprod. 3: 86–95
Kirchhoff C, Habben I, Ivell R, Krull N . 1991 Biol. Reprod. 45: 350–357
Kirchhoff C, Osterhoff C, Pera I, Schroter S . 1998 Andrologia 30: 225–232
Larramendy ML, Lushnikova T, Bjorkqvist AM, Wistuba II, Virmani AK, Shivapurkar N, Gazdar AF, Knuutila S . 2000 Cancer Genet. Cytogenet. 119: 132–138
Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D . 2000 Nature 406: 747–752
Perry AC, Jones R, Moisyadi S, Coadwell J, Hall L . 1999 Biol. Reprod. 61: 965–972
Ranganathan S, Simpson KJ, Shaw DC, Nicholas KR . 1999 J. Mol. Graph Model. 17: 106–113 134–136
Richardson RT, Sivashanmugam P, Hall SH, Hamil KG, Moore PA, Ruben SM, French FS, O'Rand M . 2001 Gene 270: 93–102
Robinson PA, Markham AF, Schalkwijk J, High AS . 1996 J. Oral Pathol. Med. 25: 135–139
Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D, Brown PO . 2000 Nat. Genet. 24: 227–235
Sallenave JM, Shulmann J, Crossley J, Jordana M, Gauldie J . 1994 Am. J. Respir. Cell Mol. Biol. 11: 733–741
Schalkwijk J, Wiedow O, Hirose S . 1999 Biochem. J. 340: 569–577
Schummer M, Ng WV, Bumgarner RE, Nelson PS, Schummer B, Bednarski DW, Hassell L, Baldwin RL, Karlan BY, Hood L . 1999 Gene 238: 375–385
Simpson KJ, Ranganathan S, Fisher JA, Janssens PA, Shaw DC, Nicholas KR . 2000 J. Biol. Chem. 275: 23074–23081
Tanner MM, Grenman S, Koul A, Johansson O, Meltzer P, Pejovic T, Borg A, Isola JJ . 2000 Clin. Cancer Res. 6: 1833–1839
Trexler M, Banyai L, Patthy L . 2001 Proc. Natl. Acad. Sci. USA 98: 3705–3709
Wang K, Gan L, Jeffery E, Gayle M, Gown AM, Skelly M, Nelson PS, Ng WV, Schummer M, Hood L, Mulligan J . 1999 Gene 229: 101–108
Xu WD, Wang LF, Miao SY, Zhao M, Fan HY, Zong SD, Wu YW, Shi XQ, Koide SS . 1996 Arch. Androl. 37: 135–141
Yamamoto S, Egami H, Kurizaki T, Ohmachi H, Hayashi N, Okino T, Shibata Y, Schalkwijk J, Ogawa M . 1997 Br. J. Cancer 76: 1081–1086
Zhang M, Magit D, Pardee AB, Sager R . 1997 Cancer Res. 57: 4631–4636
Zhang M, Zou Z, Maass N, Sager R . 1995 Cancer Res. 55: 2537–2541
Acknowledgements
We are grateful to Dr RC Read who kindly provided samples of nasal septal tissue. The UK-HGMP at Cambridge provided IMAGE clones used in this study. The study was supported in part by The Wellcome Trust.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bingle, L., Singleton, V. & Bingle, C. The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms. Oncogene 21, 2768–2773 (2002). https://doi.org/10.1038/sj.onc.1205363
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205363
Keywords
This article is cited by
-
Elevated level of serum human epididymis protein 4 (HE4) predicts disease severity and mortality in COVID-19 pneumonia
BMC Pulmonary Medicine (2023)
-
Automated classification of protein expression levels in immunohistochemistry images to improve the detection of cancer biomarkers
BMC Bioinformatics (2022)
-
A bioinformatic analysis of WFDC2 (HE4) expression in high grade serous ovarian cancer reveals tumor-specific changes in metabolic and extracellular matrix gene expression
Medical Oncology (2022)
-
Alternative splicing acts as an independent prognosticator in ovarian carcinoma
Scientific Reports (2021)
-
Comparison of Serum Human Epididymis Protein 4 (HE4) Levels in Breast Cancer Patients and Healthy Individuals
Indian Journal of Gynecologic Oncology (2021)